Tag: FOXO1

New research published in Nature sheds light on the intricate workings of chimeric antigen receptor T cell (CAR T) therapies, offering insights into why these treatments are effective and how they improve with time. The study, conducted by scientists from the Children’s Hospital of Philadelphia (CHOP) and Stanford University School of Medicine, unveils the pivotal…